Procept Biorobotics Corp Stock Alpha and Beta Analysis
| PRCT Stock | USD 97.29 1.98 1.99% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Procept Biorobotics Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Procept Biorobotics over a specified time horizon. Remember, high Procept Biorobotics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Procept Biorobotics' market risk premium analysis include:
Beta 1.31 | Alpha 0.21 | Risk 4.9 | Sharpe Ratio 0.11 | Expected Return 0.52 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Procept |
Procept Biorobotics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Procept Biorobotics market risk premium is the additional return an investor will receive from holding Procept Biorobotics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Procept Biorobotics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Procept Biorobotics' performance over market.| α | 0.21 | β | 1.31 |
Procept Biorobotics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Procept Biorobotics' Buy-and-hold return. Our buy-and-hold chart shows how Procept Biorobotics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Procept Biorobotics Market Price Analysis
Market price analysis indicators help investors to evaluate how Procept Biorobotics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Procept Biorobotics shares will generate the highest return on investment. By understating and applying Procept Biorobotics stock market price indicators, traders can identify Procept Biorobotics position entry and exit signals to maximize returns.
Procept Biorobotics Return and Market Media
The median price of Procept Biorobotics for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 80.01 with a coefficient of variation of 12.0. The daily time series for the period is distributed with a sample standard deviation of 9.87, arithmetic mean of 82.29, and mean deviation of 8.48. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 900 shares by Desai Antal Rohit of Procept Biorobotics at 76.9578 subject to Rule 16b-3 | 09/05/2024 |
2 | Disposition of 17810 shares by Desai Antal Rohit of Procept Biorobotics at 76.5984 subject to Rule 16b-3 | 09/10/2024 |
3 | Disposition of 4182 shares by Desai Antal Rohit of Procept Biorobotics at 78.6718 subject to Rule 16b-3 | 09/11/2024 |
4 | PROCEPT BioRobotics Corp Stock Price Up 3.12 percent on Sep 12 | 09/12/2024 |
5 | Disposition of 15917 shares by Kevin Waters of Procept Biorobotics at 4.52 subject to Rule 16b-3 | 09/16/2024 |
6 | Acquisition by Desai Antal Rohit of 1376 shares of Procept Biorobotics subject to Rule 16b-3 | 10/04/2024 |
7 | Acquisition by Reza Zadno of 48575 shares of Procept Biorobotics subject to Rule 16b-3 | 10/14/2024 |
8 | Disposition of 25000 shares by Kevin Waters of Procept Biorobotics at 4.56 subject to Rule 16b-3 | 10/15/2024 |
9 | PROCEPT BioRobotics Corp Stock Price Up 3.18 percent on Oct 29 | 10/29/2024 |
10 | PROCEPT BioRobotics Corp Stock Price Up 3.45 percent on Nov 4 | 11/04/2024 |
11 | Disposition of 3769 shares by Desai Antal Rohit of Procept Biorobotics at 98.2909 subject to Rule 16b-3 | 11/06/2024 |
12 | Are You Looking for a Top Momentum Pick Why PROCEPT BioRobotics Corporation is a Great Choice | 11/07/2024 |
13 | Disposition of 4510 shares by Reza Zadno of Procept Biorobotics at 95.5819 subject to Rule 16b-3 | 11/13/2024 |
14 | PROCEPT BioRobotics Corp Shares Down 4.02 percent on Nov 14 | 11/14/2024 |
15 | Disposition of 10509 shares by Reza Zadno of Procept Biorobotics at 92.7386 subject to Rule 16b-3 | 11/15/2024 |
16 | Acquisition by Alaleh Nouri of 1467 shares of Procept Biorobotics at 4.56 subject to Rule 16b-3 | 11/21/2024 |
17 | PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024 | 11/26/2024 |
About Procept Biorobotics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Procept or other stocks. Alpha measures the amount that position in Procept Biorobotics Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 9.17 | 4.04 | 4.83 | 6.79 | Days Of Inventory On Hand | 257.88 | 274.68 | 222.76 | 299.75 |
Procept Biorobotics Upcoming Company Events
As portrayed in its financial statements, the presentation of Procept Biorobotics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Procept Biorobotics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Procept Biorobotics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Procept Biorobotics. Please utilize our Beneish M Score to check the likelihood of Procept Biorobotics' management manipulating its earnings.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 25th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Procept Biorobotics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.